A lthough the establishment of an early prognosis of motor function recovery and daily life capabilities in ischemic stroke patients is difficult, 1 the World Health Organization 2 nevertheless recommends the definition of such prognostic indicators. These patients tend to spontaneously recover part of their motor function, 3 although it is difficult in the early stages of recovery to know the precise course, especially in severely affected patients. The clinical indicators used are based on the quantification of neurological scales 4 or residual strength of the paretic muscles 5 and on the observation of recovery over the first 4 weeks. 6 The introduction of neurophysiological techniques for studying motor function (transcranial electric and magnetic brain stimulation techniques) 7, 8 has allowed their application to the study of patients with motor disabilities as a result of cerebrovascular disorders. 9 Despite methodological differences, the results of the literature point to the possible prognostic utility of these techniques in predicting motor function recovery. 10 -14 More recent studies nevertheless report discordant results. [15] [16] [17] We present a prospective study using transcranial magnetic brain stimulation (TMS) in a group of patients with impaired motor function caused by acute ischemic stroke. A prolonged clinical follow-up period was involved to evaluate the prognostic utility of the technique in assessing motor and functional recovery in these patients.
Subjects and Methods

Patients
Fifty-four consecutive patients with acute ischemic stroke were recruited for 1 year from the Service of Neurology of a university hospital. Patients were included in the study when the first acute ischemic stroke had been stabilized, with motor function having been affected for Ͼ24 hours. Patients were excluded if their clinical situation did not allow them to collaborate in the study or if they presented the usual contraindications for this technique. 18 Of the total group, 4 patients were excluded from the study because their ulterior course could not be established. Thus, 50 patients were finally evaluated; their clinical characteristics are shown in Table 1 . The protocol was approved by the Hospital Research and Ethics Committee, and all patients gave informed consent to participate in the study.
Clinical Study
Stroke was diagnosed by medical history and clinical investigation, with all patients subjected to a CT scan and/or brain MRI study to evaluate infarct size and location. The patients were studied by the same researcher in the first week (first clinical examination). The clinical data on neurological status were gathered by the Canadian Neurological Scale (CNS). 19 Functional capacity was determined by the Barthel Index, 20 and control muscle strength was assessed by the Medical Research Council scale (MRC) 21 of the abductor pollicis brevis in the upper limb and of the abductor hallucis in the lower limb.
A clinical follow-up study was performed in all patients, again with application of the MRC and Barthel Index at 2 and 6 months. The patients who had totally recovered at the second month (MRCϭ5 and/or Barthelϭ100) were not studied at the sixth month. The patients who died were evaluated by the Barthel Index and MRC at the last visit. Of the total group, 11 patients died (8 before 2 months and 3 after). The last measure of the Barthel Index and/or strength index for each patient was used for the evolution study (second clinical examination). We considered clinical improvement or good recovery when the patient reached a Barthel Index of Ն60 and/or strength index in the tested hand muscle of Ն4. We analyzed only the values of hand muscle strength and the Barthel Index corresponding to the second examination, as well as the increase in strength and Barthel Index for each patient in the period between the first and second examinations. All patients were first analyzed combined (total group), followed by evaluation of patients with severely affected motor function (hand palsy, including strength in the thenar eminence muscles of degrees 0 to 1 according to the MRC).
Neurophysiological Study
The patients were studied by TMS between the third and seventh days after stroke onset by the same researcher (first TMS examination) in the Neurophysiological Laboratory. A MAGSTIM Novametrix 200 magnetic stimulator was used with a 9-cm diameter coil, capable of generating a 2-T maximum field intensity (NOVAMETRIX Inc). The motor evoked potentials (MEPs) were studied with conventional cupshaped surface electrodes in the abductor pollicis brevis muscle for the arm and on the abductor hallucis for the leg, with classic bipolar mounting (tendon-muscle). The responses were recorded by a conventional electromyograph (Mistro Medelec); the usual filters were used for motor conduction.
The TMS technique and the measurement of latencies and amplitudes were performed according to the usual protocol, 18 with 20% above-threshold and maximal stimulation output. The MEPs were obtained in the 4 extremities, healthy and affected sides, of each patient. For left hemisphere stimulation, we positioned coil face B (current counterclockwise) with the maximum stimulation band fitted tangential 3 to 4 cm lateral and posterior to the vertex to study the arm, and in the vertex midline for the leg. In the case of the right hemisphere, the coil position was reversed in position A (current clockwise). We used facilitation techniques by voluntary contraction of the homolateral target muscle or the heterolateral muscle in the case of paralyzed muscles. The time taken by the response in traveling from the brain hemisphere to the muscle was termed total conduction time. To calculate peripheral conduction time, we used magnetic radicular stimulation and cervical and lumbar sites. We obtained the central conduction time (CCT) by subtracting peripheral conduction time from total conduction time.
Absent MEP or absent CCT was defined when it failed to appear after 3 successive discharges with maximum output. Although we studied the arm and leg MEP, only the presence or absence of the arm MEP was analyzed in the final study. The MEP with the shortest latency and greatest amplitude was taken for analysis. Regarding CCT, the patients were divided into 2 groups: those with a normal CCT and those with delayed CCT. Delayed CCT was defined when it was ϾϮ2.5 SD of the CCT of the arm MEP in the control group of healthy subjects in our laboratory (Ͼ8.13 milliseconds); in this group of patients we also analyzed the difference between the healthy side and the affected side to confirm CCT prolongation. To estimate the normal values of this technique, we studied a group of 30 subjects without signs of neurological disease.
Statistical Analysis
The Mann-Whitney U test was used to compare the distributions of 2 independent samples derived from quantitative variables, while the 2 or Fisher's exact test was performed to compare proportions. The independent predictive value of the variables initial Barthel Index, initial strength, CNS, and CCT (normal, delayed, or absent) was studied by multiple linear backward regression analysis, using as dependent variable either the improvement in Barthel score (final minus initial) or the improvement in strength score. The basic requirements of the regression models were evaluated by the regression diagnostic methods described by Kleinbaum et al. 22 MEP sensitivity and specificity in predicting motor and functional outcome were calculated, and the corresponding 95% confidence intervals were also estimated. Sensitivity refers to the proportion of patients whose recovery is graded as good for the Barthel and strength scores at the second exploration and who have MEP presence in the 
Results
Regarding the CCT values obtained in the first TMS examination, the patients were divided into 3 groups. The first comprised 20 individuals with absent CCT (or absent MEP), the second 13 with delayed CCT, and the third 17 with normal CCT. In the group with severe hemiparesis (24 patients), there were 19 patients with absent CCT, 3 with delayed CCT, and 2 with normal CCT. The latter 2 patients presented prolonged CCT (although the values did not exceed the limits regarded as delayed) and combined a reduced amplitude (compared with the healthy side) of Ϸ50% to 70% with increased thresholds (Table 2) . Most patients showed motor function recovery. In this sense, recovery was reflected by the increase in Barthel Index and strength in both groups (Table 2) and by the values of these indices in the second investigation. According to the bivariate analysis (Table 3 ) regarding the total group of patients, the increase in values for strength between the first and the second examinations differed in each group according to its CCT (Pϭ0.042). Regarding the group with severe hemiparesis, the presence of CCT was associated with a significantly greater improvement in both indices.
As shown in Table 4 , the proportions of patients with MEP who exhibited good recovery were significantly higher than for patients without MEP, both in the total group of patients and in those with low levels of initial strength. On analyzing complete recovery of those patients with delayed or normal CCT (Table 4) , we found that the proportion of patients who recovered completely was greater for those with normal CCT than for those with delayed CCT, since a great majority of those patients reached the highest values for both indices.
The high sensitivity (77.1 to 87.1) and specificity (81 to 85.7) values for the total group indicate that patients with good recovery have a high probability of MEP presence in the acute stroke phase, while those with poor recovery have a high probability of absent MEP (Table 5) . Such a high positive predictive value of the test indicates that patients with MEP presence in the acute phase of stroke have a high probability of good recovery. Nevertheless, the negative predictive value is lower (in the range of 60 to 80), since the patients with absent MEP include a group who will have a good recovery. In the case of patients with greater initial weakness the sensitivity is low (36.4 to 62.5), although in contrast the specificity is very high; thus, the MEP presence has a high predictive value in this particular group of patients.
On the basis of the multiple linear regression analysis (Table  6 ), the presence of MEP (with normal or delayed CCT) and CNS was positively associated with Barthel score improvement; in contrast, the arm strength score and initial Barthel score were negatively associated with Barthel score improvement. Twentynine percent of the variation in Barthel score improvement was accounted for by this model. Likewise, in the other model, MEP presence (with normal or delayed CCT) and the initial Barthel score were positively associated with strength score improvement, whereas the initial arm strength score was negatively associated with strength score improvement. Fifty-four percent of the variation in strength score improvement was accounted for by these 3 variables.
Of those patients with MEP absence in the first examination (20 patients), 11 were again studied by TMS during recovery. Of these individuals, 4 continued to show no potential, while 7 exhibited MEP. The clinical recovery of those patients who evoked MEP was significantly better (5 good and 2 poor recoveries) than in the case of those who Values are median (range). Groups are as defined in Table 2 . *Total group of 50 stroke patients. †Group 0 -1 of MRC scale. continued to show no MEP (all with poor recoveries) (Pϭ0.04; Fisher's exact test). Of the total group of patients, 11 died: 8 before 2 months (6 without and 2 with MEP) and 3 later (with the presence of MEP). On analysis of the relationship between MEP presence and death, a statistically significant association was only found between absent MEP and early death (Pϭ0.04), with the use of Fisher's exact test. None of the patients suffered complications derived from application of the technique.
Discussion
The capacity to recover motor function is one of the most important considerations for the subsequent adaptation and recovery of ischemic stroke patients. In this context, it is essential to secure early prognostic indicators of this capacity. 2 Many patients recover variable degrees of motor function over the first 3 months, particularly in the first 4 weeks after stroke. 3 The severity of paralysis at the time of stroke is less consistently related to poor prognosis than to other indicators 5, 6 such as the presence of a previous stroke, sphincter incontinence, perceptive and cognitive losses, or low functional scores on admission.
1 Of those patients with most severe arm or hand palsy, only a limited number experience good recovery, with percentages of 15% to 27% according to different authors. 5, 23, 24 At present, no precise indicators are available to differentiate from the severely affected patients those small numbers of cases with better recovery.
TMS allows the simple and painless study of the human motor pathway in conscious subjects. 7, 8 It has been applied to patients with cerebrovascular disorders, and analyses have been made of its possible motor prognostic value. 9 The first studies were undertaken by electric transcranial brain stimulation, involving a follow-up period of 2 months. They concluded that the MEP possesses prognostic value and that CCT might correlate with clinical recovery. 10, 11, 25 Posteriorly, magnetic brain stimulation was applied with variable follow-up periods (1 to 3 months), the results again suggesting a possible predictive value for this technique. 12-14,26 -33 In this context, MEP amplitude was considered the most sensitive parameter. 30 On the basis of methodology very similar to our own, Heald et al 12,13 (1993) published the largest TMS study (118 patients with ischemic stroke) involving the longest follow-up period (12 months) to date. They concluded that the presence of MEP with normal or delayed CCT is able to differentiate a group of patients with a high probability of survival and good functional recovery. In contrast, its absence would indicate poor recovery or an increased risk of death. In their series, only 6% of patients exhibited delayed CCT, compared with 26% in our study. This may be explained by the fact that the upper limit of CCT normality used by these authors was higher than our own (Ͼ9.2 versus Ͼ8.13 milliseconds, respectively). On the other hand, the difference could also be justified by the promptness with which these authors applied stimulation (between the first and third days after stroke). In such early stages, factors such as edema or ischemic penumbra may intervene at the cerebral level, reversibly affecting the absence of potential, so that a few days later MEP appears with delayed CCT. These authors found differences in functional scores between patients with delayed CCT and normal CCT throughout the recovery period, although after 1 year the differences were not statistically significant. According to our data, statistically significant differences existed between the 2 groups of patients, with those with normal CCT presenting a better recovery.
Rapisarda et al 33 (1996) performed a TMS study of 26 acute ischemic stroke patients, with a follow-up of 14 days. These patients had a brain infarct in the sylvian region, with total hand paralysis. MEPs were present in 42.6% of patients, and their presence with an amplitude Ͼ5% that of the amplitude of the M wave implied a favorable prognosis for motor function recovery. PPV indicates predictive positive value; NPV, negative predictive value. Groups are as defined in Table 2 .
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According to these authors, MEP amplitude was of greater value than MEP latency. However, patient follow-up was very short, and although a large number of stroke patients recovered motor function mainly during the first month, some patients had slower or later recoveries. 26 In contrast to these studies in support of the prognostic value of the technique, other authors failed to corroborate its utility. Rijckevorsel-Hartman et al 15 (1993) , in a study of 27 patients followed up for 6 months, and Zgur et al 16 (1993) , in a study involving 18 patients followed up for 3 months, reported a lack of prognostic value for this technique. Arac et al 17 (1994) studied 26 patients with acute ischemic (19 patients) and hemorrhagic (8 patients) stroke using TMS with a follow-up period of 6 months and methodology similar to our own. On analyzing the recovery of their patients, they found that patients both with and without MEP recovered and that the differences between the groups were not statistically significant. Of note, however, is the fact that their percentage of patients without MEP was high (63%) in comparison with our own results, and in the patients with greatest weakness (13 patients), MEP was only present in 1 patient, compared with 20% in our series. In addition, these authors lost 22% patients to follow-up, and their sample was more heterogeneous, including ischemic and hemorrhagic strokes.
On analyzing clinical recovery by multiple linear regression analysis, we found MEP to provide information on patient recovery, regardless of the initial strength and/or Barthel values. The presence of MEP, with either normal or delayed CCT, predicted better recovery than in its absence. However, the prognostic value was more notable in the group with the most affected motor function, in which case recovery is more difficult to predict. Application of the technique would allow us to identify the small group of paralytic patients with good recovery, which cannot be identified in any other way. On the other hand, the absence of MEP does not exclude good recovery, which effectively occurs in a small percentage of these patients. Those patients without MEP who recovered well also exhibited MEP reappearance over time, ie, such reappearance during recovery constitutes a good prognostic sign. It is thus seen that the multiple regression models account for improvement of patient strength better than the improvement in the Barthel Index. This may be due to the fact that the TMS technique in particular evaluates the corticospinal motor pathway, and thus motor function, 18 while the Barthel Index depends on other factors in addition to strength. 20 The utilization by some authors 30, 33 of MEP amplitude as the most sensitive parameter involves the problem of its important variability. 26, 34 In this sense, we are of the opinion that MEP amplitude is of use when applied in combination with changes in latency and threshold (which usually occur together), while its isolated application does not contribute more information. 9 According to some authors, the study of lower limb MEP is essential to secure precision in motor prognostic value. 12, 17 In our series, we found that most patients with MEP in the arm also recorded MEP in the leg, perhaps because of the prevalence of faciobrachial paralysis distribution in our series. The absence of both forms of MEP indicated a worse recovery than when MEP was only absent in the arm. Nevertheless, interpretation of lower limb MEP is more difficult, given the inconsistency in recording these potentials, than in the case of upper limb MEP. 34 In our series, no complications and no side effects were derived from the technique. Similar observations have been reported by most authors, with some exceptions. 35, 36 In physiopathological terms, the prognostic value of the technique could be explained by considering that ischemia of the corticomotoneurons and/or corticospinal tract (responsible for motor impulse genesis and conduction) can cause partial or total, reversible or irreversible damage of these structures. 26, 37 Recovery may be due to the brain plasticity phenomenon, 38 which through cortical reorganization, 39, 40 collateral sprouting, unmasking, or other mechanisms 41 may succeed in reestablishing the damaged connections or may generate new ones with the spinal motoneuron. The application of this technique may contribute to identify such connections at an early stage, even when they are not functional for the patient. In an early stage after acute ischemic stroke, the procedure would allow us to identify those patients with less serious lesions, or with greater possibilities for recovery, who cannot be detected by traditional clinical methods. 4 In conclusion, our results support the idea that MEP obtained by TMS represents a useful early prognostic marker of motor function recovery in ischemic stroke patients. In addition, the technique could be used for monitoring and quantifying motor function, in parallel with corticospinal tract permeability, in the course of patient recovery. 
